BOCH
PLRX icon

Blue Owl Capital Holdings’s Pliant Therapeutics PLRX Stock Holding History

Blue Owl Capital Holdings’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.74M Hold
2,969,199
– – 1.01% 26
2025
Q4 		$3.62M Hold
2,969,199
– – 1.12% 26
2025
Q3 		$4.39M Hold
2,969,199
– – 1.36% 23
2025
Q2 		$3.44M Hold
2,969,199
– – 1.11% 24
2025
Q1 		$4.01M Buy
2,969,199
+200,000
+7% +$1.21M 1.29% 21
2024
Q4 		$36.5M Sell
2,769,199
-235,000
-8% -$3.21M 8.4% 3
2024
Q3 		$33.7M Hold
3,004,199
– – 6.53% 4
2024
Q2 		$32.3M Hold
3,004,199
– – 8.98% 2
2024
Q1 		$44.8M Hold
3,004,199
– – 8.94% 3
2023
Q4 		$54.4M Buy
+3,004,199
New +$45.7M 13.01% 1

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return